Computershare Calling - Pfizer feedback, page-11

This covid resurgence is going to lead to massive use of Pfizer's covid drug. By combining with RAP's covid algo, there would be a massive uplift in Pfizers drug sales as ResApps screening bring in more customers. The uplift would be many multiples that of ResApps takeover price.

There is a better way for RAP, Pfizer and humanity. That is if Pfizer give us a product license deal and let RAP get on with ResAppDX like we all wanted originally. Surely that gets every party what they want.

I'd be happy with a $10-$20 million unlimited, unexclusive licensing agreement to propel RAP on its journey, and Pfizer get what they want a lot cheaper than what they currently would need to pay. ResApp share price would be at 30c under this agreement.

Do the deal TK and Pfizer